Newsroom | 5196 results
Sorted by: Latest
-
Novigenix AI to Present Clinical Data at AACR 2026 Linking Immuno-Pharmacodynamics to Radioligand Therapy Response
EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the first time in a human clinical setting, the dynamic role of the immune system in response to radioligand therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).1 The study, conducted in collaboration with RadioMedix, Inc....
-
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...
-
Humanetics Corporation to Present at Upcoming Investor Conference
MINNEAPOLIS--(BUSINESS WIRE)--Humanetics to highlight advancements in the prophylactic Medical Countermeasure BYOGRAYZ™...
-
SinglePass Study Reaches 500 Cases as Adoption Expands Across Biopsy Workflows
LAKE FOREST, Calif.--(BUSINESS WIRE)--SinglePass Inc., a medical technology company dedicated to improving patient outcomes and procedural efficiency in interventional radiology, today announced that the B-S.A.F.E. (Biopsy Safety and Feasibility Evaluation) Study has reached 500 enrolled cases — the halfway point of its 1,000-case target. The multi-center study assesses the SinglePass Electrocautery Device — FDA cleared for liver, kidney, and lung biopsy tract cauterization and CE Marked for so...
-
MediStreams Achieves Clean SOC 2 Type II Certification, Strengthening Security in Healthcare Revenue Cycle Management and Payment Automation
ATLANTA--(BUSINESS WIRE)--MediStreams, a leading healthcare revenue cycle management company specializing in automated payment posting and reconciliation, today announced the successful completion of its SOC 2 Type II examination for the period of January 1, 2025 through December 31, 2025. The examination was conducted by Aprio LLP, an independent certified public accounting firm, in accordance with attestation standards established by the American Institute of Certified Public Accountants (AIC...
-
TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced its participation in the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting, taking place April 11–15, 2026, in Toronto, Ontario, Canada. TriSalus will showcase new clinical a...
-
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software
GUILFORD, Conn.--(BUSINESS WIRE)--Next-gen Swoop system and latest Optive AI software receive CE & UKCA marks, bringing Hyperfine’s most advanced portable MRI tech to European markets....
-
Teleflex Announces Governance Updates
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced several Board and governance updates, including the nomination of Michael J. Tokich to the Board of Directors, its intent to establish a new Growth and Operating Committee of the Board and its plan to commence share repurchases under the Company’s previously announced program ahead of schedule. The announcements reflect the Board’s continued focus on strong governanc...
-
TAE Life Sciences Announces Breakthrough BNCT Research Demonstrating Durable Tumor Control and Systemic Immune Effects
FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--TAE Life Sciences (TLS), a leader in Boron Neutron Capture Therapy (BNCT), today announced the publication of new research in ACS Pharmacology & Translational Science (an ACS journal), demonstrating that its next-generation boron delivery platform may enable both enhanced tumor control and systemic immune activation. The study introduces a novel class of proprietary BPA-based dipeptides designed to overcome key limitations of conventional BPA (borono...
-
XiFin Partners with Premier Radiology Data Intelligence Leaders Science and Medicine Group and AuntMinnie to Launch First-of-Its-Kind Radiology Research Examining Industry Challenges in 2026 and Beyond
SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-driven revenue cycle management (RCM) solutions, today announced the launch of a first-of-its-kind Radiology Perspectives Study in collaboration with Science and Medicine Group (SMG), a premier data intelligence company, and AuntMinnie, an industry-leading radiology media and insights platform. The research is designed to examine the operational, administrative, and financial challenges facing radiology groups by gathering perspectives acr...